212 related articles for article (PubMed ID: 20882522)
1. Honeydew honey as a potent antibacterial agent in eradication of multi-drug resistant Stenotrophomonas maltophilia isolates from cancer patients.
Majtan J; Majtanova L; Bohova J; Majtan V
Phytother Res; 2011 Apr; 25(4):584-7. PubMed ID: 20882522
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
Betts JW; Kelly SM; Haswell SJ
Int J Antimicrob Agents; 2011 Nov; 38(5):421-5. PubMed ID: 21885260
[TBL] [Abstract][Full Text] [Related]
3. [Clinical strains isolation and antibiotic susceptibility of Stenotrophomonas maltophilia].
Hankiewicz-Ziołkowska K; Mikucka A; Gospodarek E
Med Dosw Mikrobiol; 2010; 62(2):127-34. PubMed ID: 20873485
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
5. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
6. SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships.
Gould VC; Avison MB
J Antimicrob Chemother; 2006 Jun; 57(6):1070-6. PubMed ID: 16597633
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of varying UMF-graded Manuka honeys.
Girma A; Seo W; She RC
PLoS One; 2019; 14(10):e0224495. PubMed ID: 31652284
[TBL] [Abstract][Full Text] [Related]
8. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
Gülmez D; Hasçelik G
Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
[TBL] [Abstract][Full Text] [Related]
10. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
11. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey.
Tan HT; Rahman RA; Gan SH; Halim AS; Hassan SA; Sulaiman SA; Kirnpal-Kaur B
BMC Complement Altern Med; 2009 Sep; 9():34. PubMed ID: 19754926
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of methicillin-resistant and methicillin-sensitive Staphylococcus aureus susceptibility to Saudi honeys.
Hussain MB; Kamel YM; Ullah Z; Jiman-Fatani AAM; Ahmad AS
BMC Complement Altern Med; 2019 Jul; 19(1):185. PubMed ID: 31345195
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of some Indian honeys on Staphylococcus aureus from wounds.
Deshpande SD; Kulkarni KS
Indian J Exp Biol; 2010 Sep; 48(9):931-5. PubMed ID: 21506502
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antibacterial activity of selected Pakistani honeys against multi-drug resistant Salmonella typhi.
Hussain MB; Hannan A; Akhtar N; Fayyaz GQ; Imran M; Saleem S; Qureshi IA
BMC Complement Altern Med; 2015 Feb; 15():32. PubMed ID: 25880671
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Aug; 36(2):129-31. PubMed ID: 20472404
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.
Nicodemo AC; Araujo MR; Ruiz AS; Gales AC
J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia as a nosocomial pathogen.
Köseoğlu O; Sener B; Gülmez D; Altun B; Gür D
New Microbiol; 2004 Jul; 27(3):273-9. PubMed ID: 15460530
[TBL] [Abstract][Full Text] [Related]
19. [Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia].
Zhuo C; Qian YS; Xiao GX
Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):10-3. PubMed ID: 15059439
[TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.
Alonso A; Martinez JL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1879-81. PubMed ID: 11353642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
